About

They are a pharmaceutical laboratory specialized in identifying, developing and commercializing innovative and highly specialized medicines in Latin America.  They are focused on improving the health and quality of life of patients.

Their purpose is to solve specific problems that affect human health. They operate in 14 countries in Latin America. Their main interest is to ensure that more and more patients have access to better medicines.

Stendhal was founded in 1974, later in 1997 the company was acquired by a group of investors who gave it the approach that today distinguishes it: a company that is socially committed and attached to good practices.

Stendhal has a wide range of innovative medicines, which allows it to position itself as a unique company in the industry.  

 Currently they generate value in these therapeutic areas:

 - Anti-infectives (HIV)
 - Multiple sclerosis
 - Primary Care (HBP, diabetes, epilepsy, migraine)
 - Specialty Care (rare diseases)
 - Oncology